R. G. Wiewrodt (Mainz, Germany), R. Lucas (Augusta, United States of America)
Characterization of peripheral subsets of dendritic cells in COPD patients: preliminary data
I. Fabozzi, M. Galgani, B. Bellofiore, F. Perna, A. Vatrella, D. Galati, A. Sanduzzi, M. Bocchino (Naples, Italy)
|   |
Dipalmitoyl phosphatidycholine in induced sputum of asthmatic children as an airway inflammatory marker
K. Abdel Khalik, M. Shaheen, M. Mahmoud, M. Abdel Aziz, H. Al Morsy (Cairo, Egypt)
| |
Chemotactic dynamics of COPD neutrophils
E. Sapey, A. Ahmad, D. Bayley, R. Insall, R. Stockley (Birmingham, United Kingdom)
| |
Differently activated CD103- and CD103+ lymphocytes in lungs of healthy subjects
M. Heron, J. C. Grutters, D. Hijdra, A. M. E. Claessen, J. M. M. van den Bosch (Nieuwegein, Utrecht, Netherlands)
| |
T regulatory cells within inflammatory foci of COPD lungs
J. Plumb, L. Smyth, H. Adams, R. Eardley, J. Vestbo, A. Bentley, D. Singh (Manchester, United Kingdom)
| |
Heat shock proteins (HSP)-10 and –40 increase in bronchial biopsies of patients with severe chronic obstructive pulmonary disease
M. Carbone, I. Gnemmi, A. Zanini, A. Capelli, G. La Rocca, F. Cappello, S. E. D‘Anna, F. L. M. Ricciardolo, B. Balbi, A. Di Stefano (Veruno (NO) and Tradate, Palermo, Cefalù (PA), Torino, Italy)
| |
The level of Fas-antigens in peripheral blood, induced sputum and expired air condensate in COPD
N. Kubysheva, L. Postnikova, V. Novikov, A. Zhogota, R. Mindubaev (Nizhny Novgorod, Russian Federation)
| |
Assesment of airway remodelling in asthma by indirect methods
R. Bargava, K. A. Dar, Z. Ahmad, D. K. Pandey, N. Islam, R. Sherwani, I. Ahmed, I. U. Haq, N. N. Shah, A. A. Bachh, M. Mushtaq (Aligarh, Uttar Pradesh, Khammam, Andhra Pradesh, Srinagar, Jammu & Kashmir, India)
| |
Regulatory T-cells in sarcoidosis
A. Prasse, R. Schmiedlin, N. Lützen, J. Yalcintepe, J. Müller-Quernheim (Freiburg, Germany)
| |
Influence of tobacco smoke exposure on inflammatory cytokines and cell differentials in induced sputum – from environmental smoke exposure to active smoking and COPD
M. Huebner, O. Kornmann, C. Taube, A. Eich, R. Schubert, S. Zielen, R. Buhl (Mainz, Frankfurt/Main, Germany)
| |
Cytokine and chemokine composition of bronchoalveolar lavage fluid and exhaled breath condensate of healthy individuals
M. Nagtegaal, D. Hijdra, C. van Moorsel, J. Grutters, J. van den Bosch, G. Rijkers (Nieuwegein, Nieuwgein, Netherlands)
| |
ROS production in neutrophils is influenced by induced sputum and BAL fluid
A. Babusyte, J. Jeroch, R. Stakauskas, R. Sakalauskas (Kaunas, Lithuania; Hannover, Germany)
| |
Inflammatory mediators in exhaled breath condensate in young patients with bronchiectases
N. Rutenko, A. Baigenjin, Erlan, N. Popova, L. Ulyanova (Astana, Kazakhstan)
| |
Adenoviral infection in COPD: assessment with transrenal DNA testing
P. Panagou, G. Papatheodorou, D. Bouros (Athens, Alexandroupolis Thrace, Greece)
| |
Eosinophilic airway inflammation in COPD and asthma
K. Gorska, R. Krenke, J. Kosciuch, T. Przybylowski, J. Domagala-Kulawik, K. Hildebrand, R. Chazan (Warsaw, Poland)
| |
Role of lipoxin A4 in induced sputum of asthmatic children
R. Gagliardo, P. Chanez, S. La Grutta, L. Siena, M. Profita, A. Bonanno, M. Gjomarkaj (Palermo, Italy; Marseille, France)
| |
Adiponectin as a biomarker of systemic inflammatory response in stable and exacerbation phases of COPD
S. Kirdar, M. Serter, E. Ceylan, G. Sener, T. Kavak, F. Karadag (Aydin, Turkey)
| |
Association of sputum chitinase like protein levels with pathophysiology and neutrophilic airway inflammation in asthma
K. Otsuka, H. Matsumoto, A. Niimi, M. Yamaguchi, N. Matsuoka, M. Jinnai, T. Oguma, T. Takeda, I. Ito, H. Nakaji, M. Mishima (Kyoto, Japan)
| |
Regulatory cells in COPD patients. Preliminary report
R. Fijalkowski, J. Domagala-Kulawik, M. Dabrowska, G. Hoser, R. Chazan (Warsaw, Poland)
| |
Cytotoxic T cells are related to smoking habits in COPD
E. Roos-Engstrand, B. Ekstrand-Hammarström, J. Pourazar, A. F. Behndigh, A. Bucht, A. Blomberg (Umeå, Sweden)
| |